Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Understanding the zero based budget creation process is key to financial freedom. Learn how to effectively allocate every dollar.
19,586 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Boeing’s June performance marks more than a monthly milestone. With 64 jets delivered, the company nudges its cash fl...
A large insider stake in Veris Residential stock signals conviction from an established manager. This article explain...
Cava's yearly revenue just crossed the $1 billion mark, signaling a major milestone for the fast-casual chain. This a...
Bank of America issues two contrasting Buy ratings, backing Tesla’s autonomy roadmap and GM’s truck-led profitability...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
Bitcoin climbs back above key levels as ETF inflows resume and institutions accumulate, fueling a broad crypto-market...
A William Blair note questions near-term AI monetization for Adobe and raises questions investors are eager to answer...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
Rent the Runway announces that Jenn Hyman will step down as CEO, with a transition plan that keeps her involved as an...
Investors have seen Broadcom swing from a rough start to a strong rally. This guide breaks down whether today is the ...
Altria just posted strongest growth in years, signaling a potential turning point. But behind the headlines lie shift...